发明名称 |
Cancerous disease modifying antibodies |
摘要 |
The present invention relates to a method for producing patient cancerous disease modifying antibodies using a novel paradigm of screening. By segregating the anti-cancer antibodies using cancer cell cytotoxicity as an end point, the process makes possible the production of anti-cancer antibodies for therapeutic and diagnostic purposes. The antibodies can be used in aid of staging and diagnosis of a cancer, and can be used to treat primary tumors and tumor metastases. The anti-cancer antibodies can be conjugated to toxins, enzymes, radioactive compounds, and hematogenous cells.
|
申请公布号 |
US2008213171(A1) |
申请公布日期 |
2008.09.04 |
申请号 |
US20080102662 |
申请日期 |
2008.04.14 |
申请人 |
YOUNG DAVID S F;HAHN SUSAN E;FINDLAY HELEN P |
发明人 |
YOUNG DAVID S. F.;HAHN SUSAN E.;FINDLAY HELEN P. |
分类号 |
A61K51/10;A61K39/395;A61K39/44;A61P35/00;C07H21/04;C07K16/00;C07K16/30;C07K17/02;C12N5/00;C12N5/18;C12N9/00;G01N33/574 |
主分类号 |
A61K51/10 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|